FDA clears first new weight-loss pill in 13 years - ARNA
The Food and Drug Administration has approved Arena Pharmaceutical's anti-obesity pill Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade.
Despite only achieving modest weight loss in clinical studies, the drug appeared safe enough to win the FDA's endorsement, amid calls from doctors for new weight-loss treatments.
The agency cleared the pill Wednesday for adults who are obese or are overweight with at least one medical complication, such as diabetes or high cholesterol.
AMRN, Amarin Corporation plc
** AMRN reported that its New Drug Application for AMR101 has been accepted for filing by the FDA
AMRN is developing AMR101 for the treatment of patients with very high triglyceride levels and as a potentially first-in-class therapy for patients with high triglyceride levels who are also on statin therapy for elevated LDL-cholesterol levels.
Will Patent Protection Derail Amarin's Miracle Fish Pill?
(TISI, AMZN, ARTC) PennyOmega.com Watch List for Wednesday July 27, 2011
(BLDP, LMNX, FIS) PennyOmega.com Watch List for Wednesday July 20, 2011
Unilife Begins the Supplying of Product to Sanofi - $UNIS
Now settled-in to their new state-of-the-art facilities, Unilife has hit another milestone with the commencement of shipments of the Unifill syringe to Sanofi. This article discusses the next phase of the Unilife/Sanofi contract as well as features Alan Shortall, CEO of Unilife, in a brief video showing the proprietary syringe.
Former FDA Chief Kessler Urges Clampdown on Nicotine Levels; 22nd Century’s ($XXII) Rx-Cigs Meet the Mark
Industry leaders, such as former FDA Chief David Kessler add a great deal of credibility to the products that are being developed by 22nd Century Group. Kessler, along with people such as Harvard professor Greg Connolly have publicly commented on the FDA not exercising their authority to mandate lower levels of nicotine in cigarettes.
(ABT, SPPI, ORFG, MDAV) PennyOmega.com Stocks in Action
ABT, SVU, ORFG, PNCL, GRHU, BRKR - Stock Market Highlights From PennyOmega.com - Presentation Tomorrow At 10AM ET!!
Bruker Corporation (NASDAQ:BRKR) will present at the Deutsche Bank 36th Annual Healthcare Conference on Monday, May 2nd, 2011, at 10 a.m. Eastern Daylight Time at the InterContinental Boston. A live audio webcast of this presentation will be available on the Investor section of the Company's Web site at http://ir.bruker.com
AUTH, ABT, GEVO, ORFG, CX, GRHU - Afternoon Stock Market Highlights Plus 2 Great Videos From DrStockPick.com!!
Gevo, Inc. (NASDAQ:GEVO), a renewable chemicals and advanced biofuels company, reported that the Company will host a conference call to report its financial results and recent corporate highlights for the first quarter ended March 31, 2011 on Friday, May 6, 2011 at 8:30 a.m. EDT (6:30 a.m. MDT).